Shopping Cart 0
Cart Subtotal
AED 0

Asia- Pacific Clinical Trial Services Market _Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 9175

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 11744

Details

Asia Pacific clinical trial supplies market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Prominent factors driving the growth of this market are demand in clinical trials worldwide, Increasing Incidences of diseases, government funds to R&D investments and development of new treatments such as personalized medicine leading the clinical trial supplies market to grow in the future in market.

The key market players for Asia Pacific clinical trial services market are listed below:

Thermo Fisher Scientific Inc.,

Catalent, Inc.

Clinigen Group plc.

PAREXEL International Corporation

PCI Pharma Services

Almac Group

PAREXEL International Corporation

KLIFO

Bionical Ltd.

Alium Medical Limited

MYODERM

Clinigen Group plc.

Ancillare, LP

SIRO Clinpharm

CLINICAL SUPPLIES MANAGEMENT HOLDINGS, Inc.

The Asia Pacific clinical trial supplies market is segmented into:

Services

Clinical phases

Therapeutic uses

End User

On the basis of services Asia Pacific clinical trial supplies market is segmented into storage, manufacturing, packaging and labelling and distribution. In 2018, storage segment is expected to dominate the Asia Pacific clinical trial supplies market with the highest market share. On the basis of clinical phases the Asia Pacific clinical trial supplies market is segmented into phase III, phase II, phase IV and phase I

On the basis of therapeutic use the Asia Pacific clinical trial supplies market is segmented into oncology, cardiovascular disease, dermatology, metabolic disorders, infectious diseases, respiratory diseases, CNS and mental disorders, blood disorders and others.

On the basis of end user the Asia Pacific clinical trial supplies market is segmented into contract research organizations and pharmaceutical and biotechnology companies.

Based on countries, the market is segmented into counties:

China

JAPAN

India

Australia

South Korea

Malaysia

Thailand

Singapore

Indonesia

Philippines

Rest of Asia-Pacific

Covered in this report

The report covers the present scenario and the growth prospects of the Asia Pacific Asia Pacific clinical trial supplies market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

READ MORE

Table Of Content

Scope

Table Of Contents

1 Introduction 18

1.1 Objectives Of The Study 18

1.2 Market Definition 18

1.3 Overview Of Asia-Pacific Clinical Trial Supplies Market 19

1.4 Currency And Pricing 20

1.5 Limitation 20

1.6 Markets Covered 21

2 Market Segmentation 23

2.1 Markets Covered 23

2.2 Geographic Scope 24

2.3 Years Considered For The Study 25

2.4 Currency And Pricing 25

2.5 Research Methodology 26

2.6 Primary Interviews With Key Opinion Leaders 29

2.7 DBMR Market Challenge Matrix 30

2.8 Secondary Sources 31

2.9 Assumptions 31

3 Market Overview 32

3.1 Drivers 34

3.1.1 Rising Demand Of Clinical Trials Worldwide 34

3.1.2 Increasing Incidences Of Diseases 35

3.1.3 Government Funds To R&D Investments 36

3.1.4 Development Of New Treatments Such As Personalized Medicine 36

3.2 Restraints 37

3.2.1 Adverse Effects Of Clinical Trials 37

3.2.2 Transportation Issue 37

3.3 Opportunities 38

3.3.1 New Drug Development And Availability In Emerging Countrires 38

3.4 Challenges 39

3.4.1 Longer Procedure Time Of Clinical Trials Approval 39

4 Executive Summary 40

5 Premium Insights 42

6 Asia-Pacific Clinical Trial Supplies Market, By Services 44

6.1 Overview 45

6.2 Storage 47

6.3 Manufacturing 49

6.4 Packaging And Labeling 50

6.5 Distribution 52

7 Asia-Pacific Clinical Trial Supplies Market, By Clinical Phases 53

7.1 Overview 54

7.2 Phase Iii 56

7.3 Phase Ii 57

7.4 Phase Iv 58

7.5 Phase I 59

8 Mjkasia-Pacific Clinical Trial Supplies Market, By Therapeutic Use 61

8.1 Overview 62

8.2 Oncology 64

8.3 Cardiovascular Disease 66

8.4 Dermatology 67

8.5 Metabolic Disorders 68

8.6 Infectious Disease 69

8.7 Respiratory Diseases 70

8.8 Cns And Mental Disorders 71

8.9 Blood Disorders 72

8.10 Others 73

9 Asia-Pacific Clinical Trial Supplies Market, By End User 74

9.1 Overview 75

9.2 Contract Research Organizations 77

9.3 Pharmaceutical And Biotechnology Companies 78

10 Asia-Pacific Clinical Trial Supplies Market, By Geography 80

10.1 Asia-Pacific 80

10.1.1 China 88

10.1.2 Japan 90

10.1.3 India 92

10.1.4 South Korea 94

10.1.5 Australia 96

10.1.6 Thailand 98

10.1.7 Malaysia 100

10.1.8 Singapore 102

10.1.9 Indonesia 104

10.1.10 Philippines 106

10.1.11 Rest Of Asia-Pacific 108

11 Asia-Pacific Clinical Trial Supplies Market, Company Landscape 109

11.1 Company Share Analysis: Asia-Pacific 109

12 Company Profile 110

12.1 Thermo Fisher Scientific Inc. 110

12.1.1 Company Overview 110

12.1.2 Revenue Analysis 110

12.1.3 Company Share Analysis 111

12.1.4 Product Portfolio 111

12.1.5 Recent Developments 112

12.2 Catalent, Inc.113

12.2.1 Company Overview 113

12.2.2 Revenue Analysis 113

12.2.3 Company Share Analysis 114

12.2.4 Product Portfolio 114

12.2.5 Recent Developments 115

12.3 Clinigen Group Plc. 116

12.3.1 Company Overview 116

12.3.2 Revenue Analysis 116

12.3.3 Revenue Analysis 117

12.3.4 Product Portfolio 117

12.3.5 Recent Developments 117

12.4 Parexel International Corporation 118

12.4.1 Company Overview 118

12.4.2 Revenue Analysis 118

12.4.3 Company Share Analysis 119

12.4.4 Product Portfolio 119

12.4.5 Recent Developments 119

12.5 Alium Medical Limited 120

12.5.1 Company Overview 120

12.5.2 Product Portfolio 120

12.5.3 Recent Developments 120

12.6 Almac Group 121

12.6.1 Company Overview 121

12.6.2 Geographic Presence 121

12.6.3 Product Portfolio 122

12.6.4 Recent Developments 122

12.7 Ancillare, Lp 123

12.7.1 Company Overview 123

12.7.2 Geographic Presence 123

12.7.3 Product Portfolio 124

12.7.4 Recent Developments 124

12.8 Biocair 125

12.8.1 Company Overview 125

12.8.2 Product Portfolio 125

12.8.3 Recent Developments 125

12.9 Bionical Ltd. 126

12.9.1 Company Overview 126

12.9.2 Gepographic Presence 126

12.9.3 Product Portfolio 127

12.9.4 Recent Developments 127

12.10 Clinical Supplies Management Holdings, Inc. 128

12.10.1 Company Overview 128

12.10.2 Geographic Presence 128

12.10.3 Product Portfolio 129

12.10.4 Recent Developments 129

12.11 Klifo 130

12.11.1 Company Overview 130

12.11.2 Geographic Presence 130

12.11.3 Product Portfolio 131

12.11.4 Recent Developments 131

12.12 Movianto 132

12.12.1 Company Overview 132

12.12.2 Geographic Presence 132

12.12.3 Product Portfolio 133

12.12.4 Recent Developments 133

12.13 Myoderm 134

12.13.1 Company Overview 134

12.13.2 Geographic Presence 134

12.13.3 Product Portfolio 135

12.13.4 Recent Developments 135

12.14 Pci Pharma Services 136

12.14.1 Company Overview 136

12.14.2 Geographic Presence 136

12.14.3 Product Portfolio 137

12.14.4 Recent Developments 137

12.15 Sharp 138

12.15.1 Company Overview 138

12.15.2 Geographic Presence 138

12.15.3 Product Portfolio 139

12.15.4 Recent Developments 140

12.16 Siro Clinpharm 141

12.16.1 Company Overview 141

12.16.2 Geographic Presence 141

12.16.3 Product Portfolio 142

12.16.4 Recent Developments 142

13 Related Reports 143


List Of Figure

List Of Figures

Figure 1 Asia-Pacific Clinical Trial Supplies Market: Segmentation 18

Figure 2 Asia-Pacific Clinical Trial Supplies Market: Data Triangulation 21

Figure 3 Asia-Pacific Clinical Trial Supplies Market: Droc Analysis 22

Figure 4 Asia-Pacific Clinical Trial Supplies Market:Bottom Up Approach 23

Figure 5 Asia-Pacific Clinical Trial Supplies Market:Top Down Approach 23

Figure 6 Asia-Pacific Clinical Trial Supplies Market: Interview Demographics 24

Figure 7 Asia-Pacific Clinical Trial Supplies Market: The Market Challenge Matrix 25

Figure 8 Drivers, Restraints, Opportunities And Challenges Of Asia-Pacific Clinical Trial Supplies Market 28

Figure 9 Asia-Pacific Clinical Trial Supplies Market: Segmentation 36

Figure 10 Rising Demand Clinical Trials Worldwide, Increasing Incidences Of Diseases To Drive The Market For Clinical Trial Supplies Market In The Forecast Period 2018 To 2025 37

Figure 11 Storage Segment Is Expected To Account For The Largest Share Of The Clinical Trial Supplies Market In 2018 & 2025 38

Figure 12 Asia-Pacific Clinical Trial Supplies Market: By Services, 2017 40

Figure 13 Asia-Pacific Clinical Trial Supplies Market: By Clinical Phases, 2017 49

Figure 14 Asia-Pacific Clinical Trial Supplies Market: By Therapeutic Use, 2017 57

Figure 15 Asia-Pacific Clinical Trial Supplies Market: By End User , 2017 70

Figure 16 Asia-Pacific Clinical Trial Supplies Market: Snapshot (2017) 76

Figure 17 Asia-Pacific Clinical Trial Supplies Market: By Country (2017) 77

Figure 18 Asia-Pacific Clinical Trial Supplies Market: By Country (2018 & 2025) 77

Figure 19 Asia-Pacific Clinical Trial Supplies Market, By Country (2017 & 2025) 78

Figure 20 Asia-Pacific Clinical Trial Supplies Market, By Services (2018 -2025) 78

Figure 21 Asia-Pacific Clinical Trial Supplies Market: Company Share 2017 (%) 104


List Of Table

List Of Tables

Table 1 Asia-Pacific Clinical Trial Supplies Market, By Services , USD Million (2016 -2025) 42

Table 2 Asia-Pacific Storage In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 44

Table 3 Asia-Pacific Manufacturing In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 45

Table 4 Asia-Pacific Packaging And Labeling In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 47

Table 5 Asia-Pacific Distribution In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 48

Table 6 Asia-Pacific Clinical Trial Supplies Market, By Clinical Phases, USD Million (2016 -2025) 51

Table 7 Asia-Pacific Phase Iii In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 52

Table 8 Asia-Pacific Phase Ii In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 53

Table 9 Asia-Pacific Phase Iv In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 54

Table 10 Asia-Pacific Phase I In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 56

Table 11 Asia-Pacific Clinical Trial Supplies Market, By Therapeutic Uses, 2016-2025 (USD Million) 59

Table 12 Asia-Pacific Oncology In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 61

Table 13 Asia-Pacific Cardivascular Diseases In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 62

Table 14 Asia-Pacific Dermatology In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 63

Table 15 Asia-Pacific Metabolic Disorders In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 64

Table 16 Asia-Pacific Infectious Diseases In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 65

Table 17 Asia-Pacific Respiratory Diseases In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 66

Table 18 Asia-Pacific Cns And Mental Disorders In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 67

Table 19 Asia-Pacific Blood Disorders In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 68

Table 20 Asia-Pacific Others In Clinical Trial Supplies Market, By Region, 2016-2025 (USD Million) 69

Table 21 Asia-Pacific Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 72

Table 22 Asia-Pacific Contract Research Organizations In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 73

Table 23 Asia-Pacific Pharmaceutical And Biotechnology Companies In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 74

Table 24 Asia-Pacific Clinical Trial Supplies Market , By Country, USD Million (2016-2025) 80

Table 25 Asia-Pacific Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 81

Table 26 Asia-Pacific Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 82

Table 27 Asia-Pacific Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 82

Table 28 Asia-Pacific Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 83

Table 29 China Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 84

Table 30 China Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 84

Table 31 China Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 85

Table 32 China Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 85

Table 33 Japan Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 86

Table 34 Japan Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 86

Table 35 Japan Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 87

Table 36 Japan Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 87

Table 37 India Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 88

Table 38 India Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 88

Table 39 India Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 89

Table 40 India Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 89

Table 41 South Korea Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 90

Table 42 South Korea Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 90

Table 43 South Korea Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 91

Table 44 South Korea Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 91

Table 45 Australia Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 92

Table 46 Australia Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 92

Table 47 Australia Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 93

Table 48 Australia Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 93

Table 49 Thailand Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 94

Table 50 Thailand Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 94

Table 51 Thailand Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 95

Table 52 Thailand Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 95

Table 53 Malaysia Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 96

Table 54 Malaysia Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 96

Table 55 Malaysia Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 97

Table 56 Malaysia Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 97

Table 57 Singapore Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 98

Table 58 Singapore Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 98

Table 59 Singapore Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 99

Table 60 Singapore Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 99

Table 61 Indonesia Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 100

Table 62 Indonesia Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 100

Table 63 Indonesia Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 101

Table 64 Indonesia Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 101

Table 65 Philippines Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 102

Table 66 Philippines Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 102

Table 67 Philippines Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 103

Table 68 Philippines Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 103

Table 69 Rest Of Asia-Pacific Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 104

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Thermo Fisher Scientific Inc.,

Catalent, Inc.

Clinigen Group plc.

PAREXEL International Corporation

PCI Pharma Services

Almac Group

PAREXEL International Corporation

KLIFO

Bionical Ltd.

Alium Medical Limited

MYODERM

Clinigen Group plc.

Ancillare, LP

SIRO Clinpharm

CLINICAL SUPPLIES MANAGEMENT HOLDINGS, Inc.

Company Profile

Company Profile Title

Asia Pacific clinical trial supplies market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Prominent factors driving the growth of this market are demand in clinical trials worldwide, Increasing Incidences of diseases, government funds to R&D investments and development of new treatments such as personalized medicine leading the clinical trial supplies market to grow in the future in market.

The key market players for Asia Pacific clinical trial services market are listed below:

Thermo Fisher Scientific Inc.,

Catalent, Inc.

Clinigen Group plc.

PAREXEL International Corporation

PCI Pharma Services

Almac Group

PAREXEL International Corporation

KLIFO

Bionical Ltd.

Alium Medical Limited

MYODERM

Clinigen Group plc.

Ancillare, LP

SIRO Clinpharm

CLINICAL SUPPLIES MANAGEMENT HOLDINGS, Inc.

The Asia Pacific clinical trial supplies market is segmented into:

Services

Clinical phases

Therapeutic uses

End User

On the basis of services Asia Pacific clinical trial supplies market is segmented into storage, manufacturing, packaging and labelling and distribution. In 2018, storage segment is expected to dominate the Asia Pacific clinical trial supplies market with the highest market share. On the basis of clinical phases the Asia Pacific clinical trial supplies market is segmented into phase III, phase II, phase IV and phase I

On the basis of therapeutic use the Asia Pacific clinical trial supplies market is segmented into oncology, cardiovascular disease, dermatology, metabolic disorders, infectious diseases, respiratory diseases, CNS and mental disorders, blood disorders and others.

On the basis of end user the Asia Pacific clinical trial supplies market is segmented into contract research organizations and pharmaceutical and biotechnology companies.

Based on countries, the market is segmented into counties:

China

JAPAN

India

Australia

South Korea

Malaysia

Thailand

Singapore

Indonesia

Philippines

Rest of Asia-Pacific

Covered in this report

The report covers the present scenario and the growth prospects of the Asia Pacific Asia Pacific clinical trial supplies market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

READ MORE

Scope

Table Of Contents

1 Introduction 18

1.1 Objectives Of The Study 18

1.2 Market Definition 18

1.3 Overview Of Asia-Pacific Clinical Trial Supplies Market 19

1.4 Currency And Pricing 20

1.5 Limitation 20

1.6 Markets Covered 21

2 Market Segmentation 23

2.1 Markets Covered 23

2.2 Geographic Scope 24

2.3 Years Considered For The Study 25

2.4 Currency And Pricing 25

2.5 Research Methodology 26

2.6 Primary Interviews With Key Opinion Leaders 29

2.7 DBMR Market Challenge Matrix 30

2.8 Secondary Sources 31

2.9 Assumptions 31

3 Market Overview 32

3.1 Drivers 34

3.1.1 Rising Demand Of Clinical Trials Worldwide 34

3.1.2 Increasing Incidences Of Diseases 35

3.1.3 Government Funds To R&D Investments 36

3.1.4 Development Of New Treatments Such As Personalized Medicine 36

3.2 Restraints 37

3.2.1 Adverse Effects Of Clinical Trials 37

3.2.2 Transportation Issue 37

3.3 Opportunities 38

3.3.1 New Drug Development And Availability In Emerging Countrires 38

3.4 Challenges 39

3.4.1 Longer Procedure Time Of Clinical Trials Approval 39

4 Executive Summary 40

5 Premium Insights 42

6 Asia-Pacific Clinical Trial Supplies Market, By Services 44

6.1 Overview 45

6.2 Storage 47

6.3 Manufacturing 49

6.4 Packaging And Labeling 50

6.5 Distribution 52

7 Asia-Pacific Clinical Trial Supplies Market, By Clinical Phases 53

7.1 Overview 54

7.2 Phase Iii 56

7.3 Phase Ii 57

7.4 Phase Iv 58

7.5 Phase I 59

8 Mjkasia-Pacific Clinical Trial Supplies Market, By Therapeutic Use 61

8.1 Overview 62

8.2 Oncology 64

8.3 Cardiovascular Disease 66

8.4 Dermatology 67

8.5 Metabolic Disorders 68

8.6 Infectious Disease 69

8.7 Respiratory Diseases 70

8.8 Cns And Mental Disorders 71

8.9 Blood Disorders 72

8.10 Others 73

9 Asia-Pacific Clinical Trial Supplies Market, By End User 74

9.1 Overview 75

9.2 Contract Research Organizations 77

9.3 Pharmaceutical And Biotechnology Companies 78

10 Asia-Pacific Clinical Trial Supplies Market, By Geography 80

10.1 Asia-Pacific 80

10.1.1 China 88

10.1.2 Japan 90

10.1.3 India 92

10.1.4 South Korea 94

10.1.5 Australia 96

10.1.6 Thailand 98

10.1.7 Malaysia 100

10.1.8 Singapore 102

10.1.9 Indonesia 104

10.1.10 Philippines 106

10.1.11 Rest Of Asia-Pacific 108

11 Asia-Pacific Clinical Trial Supplies Market, Company Landscape 109

11.1 Company Share Analysis: Asia-Pacific 109

12 Company Profile 110

12.1 Thermo Fisher Scientific Inc. 110

12.1.1 Company Overview 110

12.1.2 Revenue Analysis 110

12.1.3 Company Share Analysis 111

12.1.4 Product Portfolio 111

12.1.5 Recent Developments 112

12.2 Catalent, Inc.113

12.2.1 Company Overview 113

12.2.2 Revenue Analysis 113

12.2.3 Company Share Analysis 114

12.2.4 Product Portfolio 114

12.2.5 Recent Developments 115

12.3 Clinigen Group Plc. 116

12.3.1 Company Overview 116

12.3.2 Revenue Analysis 116

12.3.3 Revenue Analysis 117

12.3.4 Product Portfolio 117

12.3.5 Recent Developments 117

12.4 Parexel International Corporation 118

12.4.1 Company Overview 118

12.4.2 Revenue Analysis 118

12.4.3 Company Share Analysis 119

12.4.4 Product Portfolio 119

12.4.5 Recent Developments 119

12.5 Alium Medical Limited 120

12.5.1 Company Overview 120

12.5.2 Product Portfolio 120

12.5.3 Recent Developments 120

12.6 Almac Group 121

12.6.1 Company Overview 121

12.6.2 Geographic Presence 121

12.6.3 Product Portfolio 122

12.6.4 Recent Developments 122

12.7 Ancillare, Lp 123

12.7.1 Company Overview 123

12.7.2 Geographic Presence 123

12.7.3 Product Portfolio 124

12.7.4 Recent Developments 124

12.8 Biocair 125

12.8.1 Company Overview 125

12.8.2 Product Portfolio 125

12.8.3 Recent Developments 125

12.9 Bionical Ltd. 126

12.9.1 Company Overview 126

12.9.2 Gepographic Presence 126

12.9.3 Product Portfolio 127

12.9.4 Recent Developments 127

12.10 Clinical Supplies Management Holdings, Inc. 128

12.10.1 Company Overview 128

12.10.2 Geographic Presence 128

12.10.3 Product Portfolio 129

12.10.4 Recent Developments 129

12.11 Klifo 130

12.11.1 Company Overview 130

12.11.2 Geographic Presence 130

12.11.3 Product Portfolio 131

12.11.4 Recent Developments 131

12.12 Movianto 132

12.12.1 Company Overview 132

12.12.2 Geographic Presence 132

12.12.3 Product Portfolio 133

12.12.4 Recent Developments 133

12.13 Myoderm 134

12.13.1 Company Overview 134

12.13.2 Geographic Presence 134

12.13.3 Product Portfolio 135

12.13.4 Recent Developments 135

12.14 Pci Pharma Services 136

12.14.1 Company Overview 136

12.14.2 Geographic Presence 136

12.14.3 Product Portfolio 137

12.14.4 Recent Developments 137

12.15 Sharp 138

12.15.1 Company Overview 138

12.15.2 Geographic Presence 138

12.15.3 Product Portfolio 139

12.15.4 Recent Developments 140

12.16 Siro Clinpharm 141

12.16.1 Company Overview 141

12.16.2 Geographic Presence 141

12.16.3 Product Portfolio 142

12.16.4 Recent Developments 142

13 Related Reports 143


List Of Figure

List Of Figures

Figure 1 Asia-Pacific Clinical Trial Supplies Market: Segmentation 18

Figure 2 Asia-Pacific Clinical Trial Supplies Market: Data Triangulation 21

Figure 3 Asia-Pacific Clinical Trial Supplies Market: Droc Analysis 22

Figure 4 Asia-Pacific Clinical Trial Supplies Market:Bottom Up Approach 23

Figure 5 Asia-Pacific Clinical Trial Supplies Market:Top Down Approach 23

Figure 6 Asia-Pacific Clinical Trial Supplies Market: Interview Demographics 24

Figure 7 Asia-Pacific Clinical Trial Supplies Market: The Market Challenge Matrix 25

Figure 8 Drivers, Restraints, Opportunities And Challenges Of Asia-Pacific Clinical Trial Supplies Market 28

Figure 9 Asia-Pacific Clinical Trial Supplies Market: Segmentation 36

Figure 10 Rising Demand Clinical Trials Worldwide, Increasing Incidences Of Diseases To Drive The Market For Clinical Trial Supplies Market In The Forecast Period 2018 To 2025 37

Figure 11 Storage Segment Is Expected To Account For The Largest Share Of The Clinical Trial Supplies Market In 2018 & 2025 38

Figure 12 Asia-Pacific Clinical Trial Supplies Market: By Services, 2017 40

Figure 13 Asia-Pacific Clinical Trial Supplies Market: By Clinical Phases, 2017 49

Figure 14 Asia-Pacific Clinical Trial Supplies Market: By Therapeutic Use, 2017 57

Figure 15 Asia-Pacific Clinical Trial Supplies Market: By End User , 2017 70

Figure 16 Asia-Pacific Clinical Trial Supplies Market: Snapshot (2017) 76

Figure 17 Asia-Pacific Clinical Trial Supplies Market: By Country (2017) 77

Figure 18 Asia-Pacific Clinical Trial Supplies Market: By Country (2018 & 2025) 77

Figure 19 Asia-Pacific Clinical Trial Supplies Market, By Country (2017 & 2025) 78

Figure 20 Asia-Pacific Clinical Trial Supplies Market, By Services (2018 -2025) 78

Figure 21 Asia-Pacific Clinical Trial Supplies Market: Company Share 2017 (%) 104


List Of Table

List Of Tables

Table 1 Asia-Pacific Clinical Trial Supplies Market, By Services , USD Million (2016 -2025) 42

Table 2 Asia-Pacific Storage In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 44

Table 3 Asia-Pacific Manufacturing In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 45

Table 4 Asia-Pacific Packaging And Labeling In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 47

Table 5 Asia-Pacific Distribution In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 48

Table 6 Asia-Pacific Clinical Trial Supplies Market, By Clinical Phases, USD Million (2016 -2025) 51

Table 7 Asia-Pacific Phase Iii In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 52

Table 8 Asia-Pacific Phase Ii In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 53

Table 9 Asia-Pacific Phase Iv In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 54

Table 10 Asia-Pacific Phase I In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 56

Table 11 Asia-Pacific Clinical Trial Supplies Market, By Therapeutic Uses, 2016-2025 (USD Million) 59

Table 12 Asia-Pacific Oncology In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 61

Table 13 Asia-Pacific Cardivascular Diseases In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 62

Table 14 Asia-Pacific Dermatology In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 63

Table 15 Asia-Pacific Metabolic Disorders In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 64

Table 16 Asia-Pacific Infectious Diseases In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 65

Table 17 Asia-Pacific Respiratory Diseases In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 66

Table 18 Asia-Pacific Cns And Mental Disorders In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 67

Table 19 Asia-Pacific Blood Disorders In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 68

Table 20 Asia-Pacific Others In Clinical Trial Supplies Market, By Region, 2016-2025 (USD Million) 69

Table 21 Asia-Pacific Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 72

Table 22 Asia-Pacific Contract Research Organizations In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 73

Table 23 Asia-Pacific Pharmaceutical And Biotechnology Companies In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 74

Table 24 Asia-Pacific Clinical Trial Supplies Market , By Country, USD Million (2016-2025) 80

Table 25 Asia-Pacific Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 81

Table 26 Asia-Pacific Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 82

Table 27 Asia-Pacific Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 82

Table 28 Asia-Pacific Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 83

Table 29 China Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 84

Table 30 China Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 84

Table 31 China Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 85

Table 32 China Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 85

Table 33 Japan Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 86

Table 34 Japan Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 86

Table 35 Japan Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 87

Table 36 Japan Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 87

Table 37 India Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 88

Table 38 India Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 88

Table 39 India Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 89

Table 40 India Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 89

Table 41 South Korea Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 90

Table 42 South Korea Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 90

Table 43 South Korea Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 91

Table 44 South Korea Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 91

Table 45 Australia Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 92

Table 46 Australia Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 92

Table 47 Australia Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 93

Table 48 Australia Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 93

Table 49 Thailand Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 94

Table 50 Thailand Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 94

Table 51 Thailand Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 95

Table 52 Thailand Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 95

Table 53 Malaysia Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 96

Table 54 Malaysia Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 96

Table 55 Malaysia Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 97

Table 56 Malaysia Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 97

Table 57 Singapore Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 98

Table 58 Singapore Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 98

Table 59 Singapore Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 99

Table 60 Singapore Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 99

Table 61 Indonesia Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 100

Table 62 Indonesia Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 100

Table 63 Indonesia Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 101

Table 64 Indonesia Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 101

Table 65 Philippines Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 102

Table 66 Philippines Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 102

Table 67 Philippines Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 103

Table 68 Philippines Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 103

Table 69 Rest Of Asia-Pacific Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 104

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Thermo Fisher Scientific Inc.,

Catalent, Inc.

Clinigen Group plc.

PAREXEL International Corporation

PCI Pharma Services

Almac Group

PAREXEL International Corporation

KLIFO

Bionical Ltd.

Alium Medical Limited

MYODERM

Clinigen Group plc.

Ancillare, LP

SIRO Clinpharm

CLINICAL SUPPLIES MANAGEMENT HOLDINGS, Inc.